Olsson, Tomas

16 Agosto 2018
900 Views
Professor of Neurology
the Karolinska Institutet
tomas.olsson@ki.se

Tomas Olsson is professor of Neurology at the Karolinska Institutet, Stockholm Sweden.
He is active in a large number of academic groups and societies in the neurology area. He is member of the board of the Swedish MS society, has been chairman for the previous Swedish expert committee for MS and is co-founder of the European School of Neuroimmunology (ESNI). He is also a member of the International MS societies, former president of the international Society of Neuroimmunology (ISNI) and former member executive board of the European Committee for the Treatment of Multiple Sclerosis (ECTRIMS). He is also a member of the Nobel assembly. He was a chairman of the Nobel assembly 2017.

He has been co-author of over 526 original papers, and many of them published in high impact journals like Nature Genetics, Cell, Lancet, the Journal of Experimental Medicine, the Journal of Clinical investigation and the Journal of Neuroscience. He also have around 56 reviews.

Current research interest is in the immunology, epidemiology and genetics of multiple sclerosis and its experimental models, as well as neuro-infections.

You may be interested

APSNI
2482 views

About APSNI

stine - 15 Gennaio 2020

Update on the Global Schools of Neuroimmunology We are pleased to provide an update on the Global Schools of Neuroimmunology…

University of Kentucky – Genetics/Genomics/Pharmacogenomics of Immune Function in Disease
Job Opportunities
1174 views
Job Opportunities
1174 views

University of Kentucky – Genetics/Genomics/Pharmacogenomics of Immune Function in Disease

stine - 14 Gennaio 2020

The College of Pharmacy at the University of Kentucky is recruiting in the area of Genetics/Genomics/Pharmacogenomics of Immune Function in…

ECTRIMS ONLINE LIBRARY
News
705 views
News
705 views

ECTRIMS ONLINE LIBRARY

stine - 8 Gennaio 2020

Check out the ECTRIMS ONLINE LIBRARY. Find webcasts, ePosters and abstracts from all ECTRIMS events. Click here to find more